Publications by authors named "Fernand Fontaine"

Claim this Profile
E
Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
Peter Bossuyt, Filip Baert, Francois D'Heygere, Antoine Nakad, Catherine Reenaers, Fernand Fontaine

Inflamm Bowel Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study.
Séverine Vermeire, François D'heygere, Antoine Nakad, Denis Franchimont, Fernand Fontaine

Patient Prefer Adherence· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO).
Lucas Wauters, Françoise Smets, Elisabeth De Greef, Patrick Bontems, Ilse Hoffman, Fernand Fontaine

Inflamm Bowel Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.
Laura Martelli, Arnaud Colard, Fernand Fontaine, Jacques Deflandre, Boris Bastens

Scand J Gastroenterol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up.
Elisabeth De Greef, Ilse Hoffman, Francoise Smets, Stephanie Van Biervliet, Patrick Bontems, Fernand Fontaine

J Pediatr Gastroenterol Nutr· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic findings in case of incidental colonic uptake in PET-CT how to improve PET-CT specificity?
Maxime Seivert, Olivier Plomteux, Amaud Colard, Philippe Leclercq, Demolin Gauthier, Fernand Fontaine

Acta Gastroenterol Belg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
Martine De Vos, Edouard J Louis, Jørgen Jahnsen, Jo G P Vandervoort, Maja Noman, Fernand Fontaine

Inflamm Bowel Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level.
Marie-Armelle Denis, Catherine Reenaers, Fernand Fontaine, Jacques Belaïche, Edouard Louis

Inflamm Bowel Dis· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection.
Andre Van Gossum, Olivier Dewit, Edouard Louis, Geert de Hertogh, Filip Baert, Fernand Fontaine

Inflamm Bowel Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up.
Filip Baert, Alain Schmit, Geert D'Haens, Franceska Dedeurwaerdere, Edouard Louis, Fernand Fontaine

Gastroenterology· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis